Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学CLL Clinical Trials, BTK Inhibitors

Susan O'Brien

MD

🏢UC Irvine Chao Family Comprehensive Cancer Center🌐USA

Associate Director for Clinical Science

135
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Susan O'Brien has led numerous practice defining clinical trials in chronic lymphocytic leukemia, including foundational studies of ibrutinib in treatment naive and relapsed disease. Her long term follow up data have shaped CLL treatment guidelines worldwide. She remains a prominent investigator in B cell malignancies.

Share:

🧪Research Fields 研究领域

CLL
BTK inhibitors
ibrutinib
clinical trials
hematologic malignancies

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Susan O'Brien 的研究动态

Follow Susan O'Brien's research updates

留下邮箱,当我们发布与 Susan O'Brien(UC Irvine Chao Family Comprehensive Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment